Induction of mosaic sex-linked recessive lethals in the different germ cell stages of Drosophila melanogaster by bleomycin

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 397, Issue 2, 1998, Pages 279-285

  Sadiq, May Fouad ^a   Khabour, Omar Falah ^a  

^a YARMOUK UNIVERSITY   (Jordan)

Author keywords

Bleomycin; Drosophila melanogaster; Mosaic sex linked recessive lethal; Mutation

Indexed keywords

BLEOMYCIN;

ANIMAL CELL; ARTICLE; CHEMICAL MUTAGENESIS; CHROMOSOME MOSAICISM; CHROMOSOME STRUCTURE; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; FEMALE; GENETIC STABILITY; MEIOSIS; NONHUMAN; PRIORITY JOURNAL; SEX LINKAGE; SPERMATOGENESIS;

ANIMALS; BLEOMYCIN; DROSOPHILA MELANOGASTER; FEMALE; GENES, LETHAL; GENES, RECESSIVE; GERM CELLS; HETEROZYGOTE; LINKAGE (GENETICS); MALE; MOSAICISM; SEX CHROMOSOMES;

ANIMALIA; DROSOPHILA MELANOGASTER; MELANOGASTER;

EID: 0032472893     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00226-1     Document Type: Article

References (45)

1. H. Umezawa, T. Takita The development of new bleomycins, in: K. Hellman, S.K. Carter (Eds.), Fundamentals of Cancer Chemotherapy, McGraw-Hill, New York, 1987, pp. 159-166.
2. Umezawa H., Maeda K., Takouchi T., Okami Y. New antibiotics, bleomycin A and B. J. Antibiot. A. 19:1966;200-209.
3. Vig B.K., Lewis R. Genetic toxicology of bleomycin. Mutation Res. 69:1978;319-324.
4. Watanabe K., Sakamoto K., Sasaki T. Collaborative study of interlaboratory variability in Salmonella typhimurium TA102 and TA 2638 and Esherichia coli: WP2/PKM101 and WP2 uvr/PKM101. Mutagenesis. 10:1995;235-241.
5. Wilcox P., Naidoo A., Wedd D.J., Gatehouse D.G. Comparison of Salmonella typhimurium TA102 with Esherichia coli WP2 tester strains. Mutagenesis. 5:1990;285-291.
6. Levin O.E., Hollstein M., Christman M.F., Mitchell G.L., Ames B.N. A new Salmonella tester strain (TA102) with A-T base pairs at the site of mutation detects oxidative mutagens. Proc. Natl. Acad. Sci. USA. 79:1982;7445-7449.
7. Pavon V., Esteve I., Guerrero R., Villaverde A., Gaju N. Induced mutagenesis by bleomycin in the purple sulfur bacterium Thiocapsa roseopersicina. Curr. Microbiol. 30:1995;117-120.
8. Povirk L.F. Bleomycin-induced mutagenesis in repackaged lambda phage: base substitution hot spots at the sequence G-G-G-C. Mutation Res. 180:1987;1-9.
9. Demopoulos N.A., Davies R.W., Scazzocchio C. Use of a rapid DNA sequencing system to demonstrate the induction of frameshift mutations by bleomycin. FEBS Lett. 146:1982;37-379.
10. McKoy J.F., Pleninger P., Wall L., Pramanik A., Martinez M., Moore C.W. Genetic changes and bioassays in bleomycin- and phleomycin-treated cells, and their relationship to chromosomal breaks. Mutation Res. 336:1995;19-27.
11. Ferguson L.R., Turner P.M. Mitotic crossing-over by anti-cancer drugs in Saccharomyces cerevisiae strain D5. Mutation Res. 240:1988;239-249.
12. Moore C.W. Bleomycin-induced mutation and recombination in Saccharomyces cerevisiae. Mutation Res. 58:1978;41-49.
13. Stephanou G., Demopoulos N.A. Heat shock phenomena in Aspergillus nidulans. Current Genet. 12:1987;443-448.
14. Demopoulos N.A., Kappas A., Pelecanos M. Recombinogenic and mutagenic effects of the antitumor antibiotic bleomycin in Aspergillus nidulans. Mutation Res. 102:1982;51-57.
15. Povirk L.F., Austin M.J.F. Genotoxicity of bleomycin. Mutation Res. 257:1991;127-143.
16. Muller H.J. Artificial transmutation of the gene. Science. 66:1927;84-87.
17. Graf U., Wurgler F.E., Katz A.J., Frei H., Juon H., Hall C.B., Kale P.G. Somatic mutation and recombination test in Drosophila melanogaster. Environ. Mutagen. 6:1984;153-188.
18. Cederberg H., Ramel C. Modifications of the effect of bleomycin in the somatic mutation and recombination test in Drosophila melanogaster. Mutation Res. 214:1989;69-80.
19. Demopoulos N.A., Stamatis N.D., Yannopoulos G. Induction of somatic and male crossing-over by bleomycin in Drosophila melanogaster. Mutation Res. 78:1980;347-351.
20. Traut H. Mutagenic effects of bleomycin in Drosophila melanogaster. Environ. Mutagen. 2:1980;89-96.
21. Vogel E.W., Zijlstra J.A. Somatic cell mutagenicity in Drosophila melanogaster in comparison with genetic damage in early germ cell stages. Mutation Res. 180:1987;189-200.
22. Mason J.M., Aaron C.S., Lee W.R., Smith P.O., Thakar A., Valencia R., Woodruff R.C., Wurgler F.E., Zimmering S. A guide for performing germ cell mutagenesis assays using Drosophila melanogaster. Mutation Res. 189:1987;93-102.
23. Lee W.R., Abrahamson S., Valenica R., von Halle E.S., Wurgler F.E., Zimmering S. The sex-linked recessive lethal test for mutagenesis in Drosophila melanogaster. Mutation Res. 123:1983;183-279.
24. Sadiq M., Mathew C. Production of mosaic lethals in different germ cell stages of Drosophila by N-methyl-N-nitro-N-nitroso guanidine. Mutation Res. 45:1977;31-39.
25. Abrahamson S., Wurgler F.E., Jongh C.D., Meyer H.U. How many loci on the chromosome of Drosophila melanogaster can mutate to recessive lethals? Environ. Mutagen. 2:1980;447-453.
26. Mathew C. The nature of delayed mutation after treatment with chloroethyl methanesulphonate and other alkylating agents. Mutation Res. 1:1964;163-172.
27. Kastenbaum M.A., Bowman K.O. Tables for determining the statistical significance of mutation frequencies. Mutation Res. 9:1970;527-549.
28. Edwards N.J., Tayler A.N.R., Flude E.J. Bleomycin induced inhibition of DNA synthesis in ataxia-telangiectasia cell lines. Biochem. Biophys. Res. Commun. 102:1981;610-626.
29. Kunimoto T., Hori M., Umezawa H. Mode of action of phleomycin, bleomycin and formycin on Hela S3 cells in synchronized cultures. J. Antibiot. A. 20:1967;277.
30. Bukeo T. The effects of calmodulin inhibitors (W-7, trifluoperazine) in cultured glioma cells. Okayama Igakkai Zasshi. 102:1990;465-484.
31. Osborn M., Weber K. Damaged cellular function by trifluoperazine, a calmodulin specific drug. Exp. Cell. Res. 130:1980;484-489.
32. Hait W.N., Gesmonde J.F., Lazo J.S. Effect of anti-calmodulin drug on the growth and sensitivity of C6 rat glioma-cells to bleomycin. Anticancer Res. 14:1994;1711-1721.
33. De Luca J.C., Dulout F.N., Andrieu J.M. The induction of reciprocal translocations in mouse germ cells by chemicals and ionizing radiations. Mutation Res. 202:1988;65-70.
34. Van Buul P.P.W., Goudzwaard J.H. Bleomycin-induced structural chromosomal aberrations in spermatogonia and bone-marrow cells of mice. Mutation Res. 69:1980;319-324.
35. Muller W.E.G., Zahn R.K. Bleomycin, an antibiotic that removes thymine from double stranded DNA. Progr. Nucl. Acid. Res. Mol. Biol. 22:1977;21-57.
36. Barranco S.C., Bolton W.E. cell cycle phase recovery from bleomycin-induced potentially lethal damage. Cancer Res. 37:1977;2589-2591.
37. Barranco S.C., Humphrey R.M. The effects of bleomycin on survival and cell progression in Chinese hamster cells in vitro. Cancer Res. 31:1971;1218-1223.
38. Terasema T., Yasukawa M., Umezawa H. Breaks and rejoining of DNA in cultured mammalian cells treated with bleomycin. Gann. 61:1970;513-516.
39. Bhuyan B.K., Fraser T.J. Cytotoxicity of antitumor agents in a synchronous mammalian cell system. Cancer Chemother. Rep. 58:1974;149-155.
40. Muller W.E.G., Zahn R.K. Effect of bleomycin on DNA, RNA, protein, chromatin and cell transformation by oncogenic RNA viruses. Progr. Biochem. Pharmacol. 11:1976;28-47.
41. Bennett R.A.O., Swerdlow P.S., Povirk L.F. Spontaneous cleavage of bleomycin-induced abasic sites in chromatin and their mutagenicity in mammalian shuttle vectors. Biochemistry. 32:1993;3188-3195.
42. Auerbach C. The chemical production of mutations. Science. 158:1967;1141-1147.
43. H. Endo, H. Yamagami, M. Ishzuka, K. Haribata, Bleomycin sensitivity and cell membrane, in: Advances in Antimicrobial and Antineoplastic Chemotherapy, vol. II, Proc. VII Intern. Congr. Chemotherapy, Prague, 1971, pp. 293-298.
44. 14C in mouse tumor cells. Cancer Res. 34:1974;2969-2974.
45. Van Bull P.P.W. Dose-response relationship for radiation-induced translocations in somatic and germ cells of mice. Mutation Res. 45:1977;61-68.